EPITHET—where next?
暂无分享,去创建一个
P. Sandercock | G. Hankey | J. Wardlaw | M. Dennis | A. Arauz | S. Ricci | E. Berge | A. Członkowska | K. Prasad | R. Lindley | A. Peeters | M. Celani | E. Righetti | A. Kobayashi | G. Gubitz | P. Lyrer | G. Venables | K. Matz | Karsten Bruins Slot | T. Cantisani | M. Correia | Stephen Phillips | V. Murray
[1] M. Luby,et al. Effect of the Glycine Antagonist Gavestinel on Cerebral Infarcts in Acute Stroke Patients, a Randomized Placebo-Controlled Trial: The GAIN MRI Substudy , 2006, Cerebrovascular Diseases.
[2] Keith Muir,et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.
[3] J M Wardlaw,et al. Thrombolysis for acute ischaemic stroke. , 2003, The Cochrane database of systematic reviews.
[4] P. Schellinger. EPITHET: failed chance or new hope? , 2008, The Lancet Neurology.